1372 TriTCE Co-Stim: a novel trispecific T cell engager platform, with integrated CD28 costimulation, engineered to widen the therapeutic window for treatment of poorly infiltrated tumors

1372 TriTCE Co-Stim: a novel trispecific T cell engager platform, with integrated CD28 costimulation, engineered to widen the therapeutic window for treatment of poorly infiltrated tumors

Bibliographic Details
Main Authors: Maya Poffenberger, Nichole Escalante, Diego Perez Escanda, Nina Weisser, Thomas Spreter von Kreudenstein, Lisa Newhook, Purva Bhojane, Peter Repenning, Desmond Lau, Polly Shao, Alec Robinson, Kesha Patel, Alexandra Livernois, Chayne L Piscitelli, Nicole Afacan
Format: Article
Language:English
Published: BMJ Publishing Group 2023-11-01
Series:Journal for ImmunoTherapy of Cancer

Similar Items